Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at firstname.lastname@example.org.
LONDON, BOSTON, TOKYO (September 28, 2021) - The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of…
LONDON, BOSTON, TOKYO (August 20, 2021) – By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial…
LONDON, BOSTON, TOKYO (June 21, 2021) – Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is pleased to…
Evaluate Vantage releases annual analysis of Pharma, Biotech and Medtech performance
Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2019
Evaluate Ltd. releases annual “EvaluateMedtech World Preview 2018, Outlook to 2024” in conjunction with The Medtech Conference
Vantage releases its half-year analysis of sector performance: Pharma, Biotech and Medtech Half-Year Review 2018
Eleventh annual EvaluatePharma World Preview 2018, Outlook to 2024 report launches at BIO 2018.
Annual “EvaluatePharma Orphan Drug 2018 Report” sees Orphan drugs capture a fifth of worldwide prescription sales by 2024 as sales grow to $262bn.
EP Vantage releases its annual analysis of sector performance: Pharma, Biotech and Medtech 2017 in Review.
EP Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2018.
EvaluateMedTech Report Launches in Conjunction with The MedTech Conference.